Why is AI struggling to discover new drugs?
A generation of start-ups have failed to live up to the hype. Executives are now betting that more powerful tools will crack the complexities of human biology
Related reading
How AI can recode the difficult process of drug discovery
Research organisations are banking on technology to help improve the odds of approval
Why it’s hard for humans to have the final say over AI
We need to learn from the mistakes we have made in the past
Investors are betting on AI chaos. History suggests otherwise
The experience of past tech revolutions suggests savvy incumbents might muddle through and even thrive
OpenAI says new GPT-5 model speeds up research in maths and science
Development comes as tech groups bet on potential for AI to accelerate drug discovery and uncover new materials
Meta plans big bet on AI’s secret ingredient: human brains
Decent data for training AI models is becoming scarce and people are needed to make more of it
US tech stocks hit by concerns over future of AI boom
Warning from OpenAI’s Sam Altman and MIT paper puncture Wall Street’s enthusiasm